Cargando…
Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection
Autores principales: | Bian, Jingwei, Zhao, Rongsheng, Zhai, Suodi, Li, Zijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195321/ https://www.ncbi.nlm.nih.gov/pubmed/32363137 http://dx.doi.org/10.1016/j.apsb.2020.04.013 |
Ejemplares similares
-
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design
por: Moghnieh, Rima, et al.
Publicado: (2022) -
Reply to the letter to the editor: “impact of SARS-CoV-2 vaccines on the nervous system”
por: Corrêa, Diogo Goulart, et al.
Publicado: (2022) -
Reply to Letter to Editor: Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
por: Kamel, Walaa A., et al.
Publicado: (2021) -
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
por: Bian, Jingwei, et al.
Publicado: (2021) -
Response to letter to the editor “Does SARS-CoV-2 truly cause infectious myopathy?”
por: Chang, Kai Chieh
Publicado: (2021)